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Abstract
In this chapter, we describe the histophysiology of human Leydig cells, their cytologi-
cal characteristics, their differentiation processes, and the physiopathological processes 
occurring at various times throughout life. We first focus on the normal development 
of fetal Leydig cells as well as the pathologies of fetal Leydig cells that can affect num-
bers or hyperplasic processes (e.g., hypogonadotropic hypogonadism, cryptorchidism, 
congenital Leydig cell hyperplasia secondary to diabetes, and isoimmunization). Next, 
we explain the changes occurring at puberty with the onset and differentiation of 
adult Leydig cells and the pathophysiology of delayed puberty. We then describe the 
histophysiology of adult Leydig cells and the most frequent pathologies (e.g., hypogo-
nadotropic hypogonadism, testicular dysgenesia, mild androgen insensitivity syndrome, 
5-α-reductase defect, and Klinefelter syndrome). Finally, we discuss the morphological 
changes of these cells in the elderly.
Keywords: fetal Leydig cells, adult Leydig cells, testosterone, puberty, elderly, 
dysgenesia, pathology
1. Introduction
Leydig cells are the primary producers of testosterone. They perform important functions 
during fetal life, in the first months of life, and in adults, ranging from male sexual differentia-
tion and testicular descent to the acquisition of a normal number of spermatogonial stem cells, 
the development of spermatogenesis and thus fertility, and the maintenance of typical male 
characteristics in adulthood.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Fetal stage
2.1. Origin and development of fetal Leydig cells
During development, two different types of Leydig cells appear sequentially, fetal Leydig 
cells and adult Leydig cells, which display different functional characteristics, reflecting their 
morphology, steroid capacity, and regulatory mechanisms. Fetal Leydig cells are detected 
immediately after gonadal sex differentiation [1]. Adult Leydig cells begin to develop at the 
beginning of puberty and acquire their maximum numbers at the end of puberty. The origin 
of both Leydig cell types is debated: some suggest a parent-common progenitor pool in the 
fetal testis [2, 3] and others have suggested that Leydig cells in adults might originate in 
precursors to fetal Leydig cells [4]. In addition, a three-phase model of the development of 
Leydig cells has been proposed: fetal, neonatal, and adult Leydig cells [5].
2.1.1. Development of fetal Leydig cells
The mesonephros and the coelomic epithelium are considered the two most plausible origins 
of fetal Leydig cells. The progenitor cells expressing SF1 actively proliferate and ultimately 
lose this marker when cell differentiation begins in week 8 of human gestation. The first sign 
of differentiation is the histochemical detection of 3-beta hydroxysteroid dehydrogenase (3β-
HSD) in the cytoplasm. About 83% of 3β-HSD-positive cells show a high intensity of andro-
gen receptors (ARs) immunoreaction.
Fetal Leydig cells express various steroidogenic enzymes required for androgen synthesis, 
such as acute regulatory protein, CYP11A1 (P450 side chain cleavage), CYP17A1 (P450C17), 
and 3β-HSD. The most important androgenic product of fetal Leydig cells is androstenedione. 
Fetal Sertoli cells make testosterone from androstenedione through the enzyme 17-β hydroxys-
teroid dehydrogenase (HSD17β3) at this stage of fetal testis development. Differentiation of 
fetal Leydig cells has been a subject of debate in recent decades and appears to be an andro-
gen-independent process [6]. Their proliferation and subsequent development do so under 
the stimulus of human chorionic gonadotropin (hCG) in the first half of the gestation period 
and with the help of luteinizing hormone (LH) secreted by the pituitary gland in the last half. 
Both hormones are glycoproteic in nature and act through the same receptor (LHCGR).
2.1.2. Evolution throughout fetal life
Fetal Leydig cells are identified by positivity for the 3β-HSD enzyme. The maximum peak 
of Leydig cell numbers is reached at week 19 of gestation (Figure 1). Remarkably, this peak 
occurs in parallel with the disappearance of one of the two layers of peritubular cells of the 
seminiferous epithelium, the outermost layer of peritubular cells, between weeks 17 and 19 
of gestation. These two occurrences also match the maximum production of testosterone 
between the 14th and 19th weeks of fetal life. After a few weeks of Leydig cell quiescence, 
from week 22 of gestation, a progressive decrease in the number of Leydig cells is observed.
Most fetal Leydig cells disappear after birth; however, a subpopulation persists in the postna-
tal testis that is estimated to represent 10% of all Leydig cells in adulthood [7–9]. Given that 
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fetal Leydig cells do not express HSD17β3, they cannot directly synthesize testosterone; thus, 
their functional importance in adults is unknown.
2.2. Functions of fetal Leydig cells
2.2.1. Differentiation of the genitals
Under the action of testosterone, the differentiation of the Wolff tubes takes place. This dif-
ferentiation is ipsilateral and gives rise to the development of the epididymis, vas deferens, 
and seminal vesicle. When testosterone is converted into dihydrotestosterone by the enzyme 
5-α-reductase, differentiation of the prostate and development of the external genitalia occur: 
male urethra, penis, and scrotum.
2.2.2. Testicular descent
The two stages of testicular descent, transabdominal and inguinoscrotal, are controlled 
directly or indirectly by fetal Leydig cells. Transabdominal descent depends on an androgen-
independent peptide, insulin-like growth factor 3 (INLS3), whereas inguinoscrotal descent is 
mediated by androgens through the masculinization they produce in the genitofemoral nerve 
neurons. Those neurons produce calcitonin gene-related peptide (CGRP), which is respon-
sible for the development that the gubernaculum acquires, allowing testicle descent [10].
2.3. Pathology of fetal Leydig cells
2.3.1. Defective androgen synthesis
Defects in the synthesis of androgens due to various autosomal hereditary syndromes result 
in absent or incomplete virilization. They include lipoid congenital adrenal hyperplasia 
(lipoid CAH), deficits in 3-βHSD/17,20-lyase, α-hydroxylase 17/17,20-lyase deficiency, deficit 
in 17,20 desmolase, and deficit in 17-β hydroxysteroid dehydrogenase.
Figure 1. Fetus at 19 weeks. Seminiferous tube showing two gonocytes in the center, with the remaining cells, the Sertoli 
cells. In the interstitium, Leydig cells with peripheral nuclei and broad eosinophilic cytoplasm are abundantly found.
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2.3.1.1. Lipoid CAH
It is the most severe form of congenital adrenal hyperplasia. It affects the synthesis of adrenal 
and gonadal steroid hormones. Genetically 46,XY patients are phenotypically women with 
severe salt-losing syndrome. There is no uniformity in the histological descriptions of the 
Leydig cells; in some cases, they are described as having large accumulations of lipids [11], 
whereas in others, such lipid inclusions are absent [12].
2.3.1.2. 3-βHSD/17,20-lyase deficit
Patients with a mild deficiency have normal external genitalia; some consult for hypospadias 
or micropenis [13], and the testicles are smaller than normal.
2.3.1.3. 17-α Hydroxylase/17,20-lyase deficiency
Patients have a significant degree of undermasculinization; they can even mature as girls and 
consult at puberty for amenorrhea. The testes show a delay in pubertal development and 
hyperplasia of Leydig cells.
2.3.1.4. 17,20 Desmolase deficit
It presents with a high variability in external genital development, from a female pheno-
type to males with micropenis that is hardly virilized, bifid scrotum, perineal hypospa-
dias, and cryptorchidism, due to the insufficient production of testosterone during fetal 
life.
2.3.1.5. 17-β-Hydroxysteroid dehydrogenase deficit
Patients show a female phenotype at birth, grow up as girls, and suffer significant virilization 
at puberty. The cryptorchid testis or testis housed in the labia majora has low spermatogen-
esis development, testicular mixed atrophy, Sertoli cell-only testis histology, and in all cases, 
Leydig cell hyperplasia [14].
2.3.2. Hypoplasia of Leydig cells
Inactivating mutations in the LHCGR gene, primarily those involving amino acid sequences, 
result in a rare 46,XY disorder in sexual development (DSD) [15]. A spectrum of phenotypes 
can occur, ranging from a severe form with a female phenotype (Leydig cell hypoplasia 
(LCH) type I) when various mutations, deletions, or insertions produce a complete inactiva-
tion of LHCGR to a milder form of LCH (type II) when some receptor activity is maintained 
with male undervirilization (delayed puberty, primary hypogonadism, micropenis, or 
hypospadias) [16]. The testes in patients with LCH type I remain in the adult as a pattern of 
infant development with an absence of germ cells and Leydig cells. The epididymides and 
vas deferens are absent or hypoplastic. In patients with LCH type II, a pattern similar to the 
previous one has been reported, with the presence of small groups of Leydig cells and focal 
spermatogenesis [17].
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2.3.3. Transient androgenic insufficiency
Testicular descent is a complex process in which multiple factors are involved sequentially 
and synergistically, highlighting the role of the hypothalamic-pituitary-testicular axis. 
Congenital cryptorchidism has been linked to a hormonal dysfunction, emphasizing the role 
of testosterone. Androgenic insufficiency during the second and third trimesters of pregnancy 
secondary to poor stimulation of the Leydig cells either by the pituitary hormones or by HCG 
has been suggested. This insufficiency might be low and transient given that no other genital 
anomalies except epididymal anomalies are present [18].
2.3.4. Congenital hyperplasia of Leydig cells
The presence in the newborn of a nodular or a diffuse Leydig hyperplasia is most often due to 
hyperstimulation by the mother’s hCG, which, under certain conditions, can pass to the fetus 
in large quantities (Figure 2).
Children of mothers with diabetes who have very edematous placentas could suffer this 
phenomenon. It has also been observed in triploid fetuses, in newborns with Beckwitz-
Wiedemann syndrome, nonimmune hydrops fetalis, Rh isoimmunization or leprechaunism, 
and in complicated pregnancies [19].
3. Neonatal stage
3.1. Mini-puberty
In the first few months of postnatal life, a second wave of Leydig cell proliferation occurs 
(Figure 3), which depends on a transient reactivation of the hypothalamic-pituitary-testicular 
axis that begins immediately after birth. This stage is known as mini-puberty and begins with 
Figure 2. Congenital Leydig cell hyperplasia in a son of a mother with diabetes. Several nodules of Leydig cells are 
observed located in the testicular mediastinum and subalbuginea region.
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an elevation in LH and follicle-stimulating hormone (FSH). Then, an increase in the number 
of Leydig cells reaches a peak in the third month after birth, and secondarily, an increase 
in the production of testosterone and estradiol [20]. This transient stimulation determines 
important changes in the various cells of the testicle. An increase in the number of Sertoli cells 
ensuring normal spermatogenesis in adult life [21] and a transformation of gonocytes into 
adult spermatogonia reaches a peak by postnatal day 100. Six months after birth, coinciding 
with the decrease in GnRH pulses, a loss of germ cells then begins. Outside the genital tract, 
mini-puberty is key to the masculinization of the brain.
3.2. Pathology of mini-puberty
The most frequent pathology at this stage of development is hypogonadotropic hypogonad-
ism, which is transient in most patients with undescended testes and permanent in other 
conditions such as Kallmann syndrome, multiple pituitary hormone deficiency, and DAX-1 
mutations [22]. The lack of gonocyte differentiation into adult spermatogonia can be the cause 
of many infertility disorders that have been considered idiopathic until now.
4. Childhood
After mini-puberty, the testicle enters a resting phase that lasts until the end of the third year of 
life. During this period, most fetal Leydig cells involute and disappear [8]. At the beginning of 
the fourth year, coinciding with the activation of the androgenic receptors in the Sertoli cells, a 
wave of proliferation and differentiation of the germ cells begins in the seminiferous tubules. 
This wave is observed at the appearance of various types of spermatogonia and type I spermato-
cytes. The purpose of this process is not well understood, but it leads to a renewal of the germ 
cells. After a short time, the most differentiated cells (the spermatocytes) undergo apoptosis and 
are phagocytosed by Sertoli cells. Until the beginning of puberty, no Leydig cells are observed 
in the interstitium but are represented by fibroblastic-like cells with some lipid vacuoles.
Figure 3. Infant of 3.5 months of age. The testicular parenchyma shows small clusters of Leydig cells between the 
seminiferous tubules. Immunostaining for inhibin in brown.
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The most frequent pathology of Leydig cells during this period is a persistence of abundant 
fetal Leydig cells and Leydig cell hyperplasia.
4.1. Persistence of fetal Leydig cells
The persistence of isolated fetal Leydig cells throughout childhood and even in adult testes is 
a normal occurrence. In any case, it is an androgen-independent subpopulation [9]. What is 
pathological is the presence of abundant Leydig cell clusters that also show a large cytoplas-
mic vacuolization due to the presence of abundant lipid inclusions. Most patients with these 
alterations are DSD carriers. The persistence of fetal Leydig cells is characteristic of the testis 
of patients with DSD with NR5A1 gene mutations (Figure 4), congenital lipoid adrenal hyper-
plasia (due to StAR mutations) [23], or a deficit of 5α-reductase and androgen insensitivity. 
These alterations are remarkable in the first years of life.
4.2. Hyperplasia of Leydig cells
The presence of abundant Leydig cells in childhood is a rare occurrence and is clinically mani-
fested by symptoms of precocious puberty. It is observed in familial testotoxicosis, in some 
cases of McCune-Albright syndrome (MAS), Leydig cell hyperplasia/Leydig cell tumor, and 
extratesticular hCG-secreting tumors.
4.2.1. Familial testotoxicosis
It is also known as gonadotropin-independent precocious puberty (GIPP) or familial male-
limited precocious puberty (FMPP) and is an autosomal-dominant disorder caused by a con-
stitutive activating mutation of the LH/CGR gene [24]. It is a form of precocious male puberty 
characterized by the early maturation of Leydig cells and spermatogenesis in the absence of 
pituitary gonadotropic stimulation [25] (Figure 5).
Figure 4. Patient with 46,XY DSD by mutation in the NR5A1 gene, showing Leydig cells in clusters and isolated between 
seminiferous tubules with a few germ cells showing highly vacuolated cytoplasms due to the high lipid content.
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4.2.2. McCune-Albright syndrome
It is considered an example of mixed peripheral and early precocious puberty. This syndrome 
is characterized by polyostotic fibrous dysplasia, “café au lait” skin pigmentation, and autono-
mous endocrine hyperfunction. At the testicular level, it is manifested by a secondary mac-
roorchidism, in some cases associated with isolated hyperfunction of the Sertoli cells, and in 
other cases to a hyperfunction of the Leydig cells without the activation of the Sertoli cells [26].
4.2.3. Leydig cell hyperplasia/Leydig cell tumor
More frequently than the above situations, hyperplasia of Leydig cells in childhood is 
observed, which manifests clinically with the same symptoms as functioning Leydig cell 
tumors. Histologically, there are several nodules of hypertrophic Leydig cells located between 
or surrounded by seminiferous tubules with complete spermatogenesis. Whether Leydig cell 
hyperplasia with focal spermatogenesis in childhood is a precursor lesion of some tumors of 
Leydig cells is a matter of debate.
4.2.4. Leydig cell hyperplasia secondary to extratesticular hCG-secreting tumors
Numerous extratesticular tumors have been described (mediastinal, retroperitoneal, basal 
ganglia, pineal, or suprasellar region) that manifest with precocious pseudopuberty. All are 
hCG secretors. Leydig cell hyperplasia is mostly moderate but could be responsible for com-
plete spermatogenesis [27].
5. Puberty
5.1. Differentiation of adult Leydig cells
The onset of puberty depends on both genetic and environmental factors. Under the action 
of gonadotropin-releasing hypothalamic hormone (GnRH), gonadotropic cell receptors of 
Figure 5. Hyperplasia of Leydig cells surrounded by seminiferous tubules with spermatogenesis in a 3-year-old patient 
with testotoxicosis.
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the anterior lobe of the pituitary gland are stimulated, and the synthesis of FSH and LH 
begins. The onset of puberty occurs around the age of 9 years. Adult Leydig cells originate 
at the onset of puberty after an active proliferation of undifferentiated stem cells. Under the 
stimulus of LH, these cells first become stellate or spindle-shaped, from either the tubular or 
perivascular wall, and begin to show steroidogenic activity. Initially, as immature cells, they 
produce 5-α-reduced androgens more than testosterone, and later when they have acquired a 
polyhedral shape, the mature cells produce testosterone. Leydig cells are arranged isolated or 
in small groups between the seminiferous tubules, which in turn are increasingly developing 
the germ line, in a proportion estimated at 1.2 groups (regardless of the number of cells) per 
cross-tubular section. The change in testicular size is rapid and detectable at an average age of 
13.5 years and is followed 1 or 2 years later by an increase in body height and the development 
of male secondary sexual characteristics.
5.2. Delay in the differentiation of adult Leydig cells
The most frequent pathology observed during puberty is a delay in the differentiation of 
Leydig cells. This delay causes an absence of or low testosterone levels, and as a consequence, 
a serious defect in spermatogenesis in the testicle occurs that is clinically expressed as delayed 
puberty. Delayed puberty is suspected when at the age of 14 years, the testis has not reached 
3 ml of volume and its major axis is less than 2.5 cm. If the defect persists beyond 18 years, the 
patient probably carries a form of hypogonadotropic hypogonadism.
5.2.1. Constitutional delay of growth and puberty (CDGP)
Delayed puberty is a symptom for which adolescents are frequently sent to the endocri-
nologist, considered a minor GnRH deficit [28]. Many cases are inherited as an autosomal-
dominant, -recessive, or X-linked trait. It is twice as frequent in boys as in girls. Although 
delayed puberty has multiple possible causes, the conjunction of elevated serum ghrelin and 
low concentrations of leptin is worth noting. Histologically, the testes remain prepubertal; no 
tubular development and adult Leydig cells are observed.
5.2.2. Delayed puberty associated with chronic illness
A number of situations can lead to delayed puberty, from malnutrition to chronic diseases 
(e.g., gastrointestinal diseases, chronic anemia, recurrent infections, immunodeficiency, respi-
ratory diseases, and endocrine diseases). Even excessive exercise at this age could be a cause. 
The testis in most cases shows isolated small-sized Leydig cells with poor immunostaining 
for testosterone.
6. Adulthood
6.1. Histophysiology of adult Leydig cells
Leydig cells represent 3.8% of the testicular volume [29]. As polyhedral cells arranged in isola-
tion or in small clusters (Figure 6), they are frequently observed in the tunica propria of the 
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seminiferous tubules (peritubular Leydig cells) and as ectopic cells (testicular mediastinum, 
interlobular septa, albuginea, epididymis, and spermatic cord).
Cellular characteristics include an eosinophilic cytoplasm and an eccentric nucleus with one 
or two nucleoli. In the cytoplasm, the machinery is at the service of the transformation of 
cholesterol into testosterone, which includes the presence of abundant lipid droplets, signifi-
cant development of the smooth endoplasmic reticulum, mitochondria with tubular crests, 
peroxisomes, and lipofuscins. Many cells contain Reinke crystals as well. Leydig cell clusters 
are joined by gap junctions.
The proper function of Leydig cells depends not only on the presence of LH receptors but a 
complex paracrine network in which Sertoli cells, germ cells, peritubular cells, macrophages, 
telocytes, and even vascular endothelial cells are involved [30]. Leydig cells show morphologi-
cal changes in relation to the six stages of the cycle of the human seminiferous epithelium [29]. In 
adulthood, they rarely show mitosis [31]. Their numbers begin to decrease slowly after puberty, 
and at 60 years, there are approximately half as many as at age 20. However, the production of 
testosterone is maintained well until the end of the fifth decade due to the high number of cells.
6.2. Pathology of adult Leydig cells
6.2.1. Alterations in number
6.2.1.1. Absence or incomplete maturation of Leydig cells
It is the characteristic histological picture of most hypogonadotropic hypogonadisms (HHs). 
They include normosmic idiopathic HH, HH with anosmia or Kallmann syndrome, and HH 
due to LH deficiency. Another situation in which a small number of Leydig cells are observed 
occurs when LH is biologically inactive.
The most frequent genetic anomalies identified as causes of normosmic idiopathic HH are those 
in genes related to the synthesis and secretion of GnRH, such as GNRHR/GNRH1, TAC3/TACR3, 
KISS1R and KISS1, FGFR1 and CHD7. In the HH associated with anosmia described by [32] and 
Figure 6. Transverse sections of seminiferous tubules with complete spermatogenesis in an adult patient. Immunostaining 
for inhibin highlights both Sertoli cell and Leydig cell clusters in the interstitium.
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many years later known as Kallmann syndrome, KAL1 gene mutations are predominant. In these 
two types of hypogonadism, serum determinations of FSH and LH are very low or undetectable. 
The testicles show a childhood or a pubertal development pattern depending on the complete 
or partial absence of GnRH. In the first case, a testicular interstitium in which Leydig cells and 
their precursors are absent or are undetectable (Figure 7) is worth noting. In the second case, in 
which patients have a low GnRH, they present pulsatile secretions of FSH and LH that ensure 
maturation of isolated Leydig cells and then some secretion of testosterone allowing for testicular 
development that is closer to that of a pubertal testis [33, 34].
In the isolated LH deficit (Pasqualini-Bur-McCullagh syndrome, fertile eunuch syndrome), serum 
levels of FSH are normal, whereas those of LH and testosterone are very low [35]. In some cases, 
the cause is a mutation in both the LH β subunit gene and in the gonadotropin-releasing hormone 
receptor. The testicles present complete but quantitatively abnormal spermatogenesis at the tubular 
level with a depopulated interstitium or very few Leydig cells. A minimum production of testos-
terone and a proper functioning of Sertoli cells needed for spermatogenesis are achieved. Among 
the many complex syndromes in which this deficit in the development of Leydig cells can be seen 
are Prader-Willi syndrome, Bardet-Biedl syndrome, Biemond syndrome, Frasser syndrome, and 
hypogonadism associated with dermatological diseases, ataxia, or central demyelination.
6.2.1.2. Focal hyperplasia of Leydig cells
It is a very common condition in ex-cryptorchid testicles, in infertile patients, and in peri-
tumoral parenchyma that has been conserved in germ cell tumors. The focal hyperplasia is 
defined by the presence of clusters of at least 14 Leydig cells and by the fact that they do 
not distort the testicular architecture, conserving the seminiferous tubules without englobing 
them. Focal hyperplasia is typically associated with poor spermatogenesis (Figure 8). Patients 
frequently suffer a decrease in testosterone/LH ratio and testosterone/estradiol ratio. The 
presence of a focal hyperplasia of the Leydig cells represents a loss of the normal paracrine 
Figure 7. Adult patient of 26 years with hypogonadotropic hypogonadism with anosmia (Kallmann’s syndrome). The 
interstitium shows a complete absence of Leydig cells. At the tubular level, binucleated spermatogonia and intense 
immunostaining for inhibin are observed in the cytoplasm of Sertoli cells.
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interactions between Sertoli cells, peritubular myoid cells, and Leydig cells. Some believe it 
to be the result of a defect in fetal life that probably depends on Sertoli cells, given that Sertoli 
cells are responsible for the quantity of Leydig stem cells [36]. Focal hyperplasia of Leydig 
cells is included among the most frequent lesions of patients with testicular dysgenesis [37].
6.2.1.3. Diffuse hyperplasia of Leydig cells
With this condition, Leydig cells are not only increased in number (hyperplasia) but often 
show hypertrophy. This hyperplasia is observed in patients with androgen insensitivity, a 
defect in 5-α reductase, DSD with dysgenetic testis, in many infertile patients of uncertain 
etiology and between the conserved seminiferous tubules of a testicle carrying a germ-cell 
tumor secreting β-hCG or even in the contralateral testis of such tumor.
The androgen resistance syndromes are a group of DSDs characterized by a 46,XY karyotype 
and phenotypes ranging from female (testicular feminization) to normal males who consult 
for infertility. The cause must be found in one of the almost 1000 mutations described in 
the AR gene. The three main forms, CAIS (complete testicular feminization), PAIS (partial 
testicular feminization), and MAIS (slight or minimal androgen insensitivity) [38], have been 
described according to the phenotype. The complete form is rarely diagnosed in childhood; 
patients consult for amenorrhea, or the testicles are an incidental finding during a hernior-
rhaphy. PAIS is diagnosed more often in childhood, associated with surgical interventions for 
the reconstruction of the external genitalia. Patients with CAIS and PAIS have a pathogno-
monic histological image: a testicular interstitium populated by numerous Leydig cells next 
to the seminiferous tubules, which, due to the absence of androgenic receptors in Sertoli cells, 
remain at infantile development (Figure 9). The Leydig cells usually do not show hyperplasia; 
many have hyperchromatic nuclei and/or abundant cytoplasmic vacuoles. Two-thirds of the 
testicles have Sertoli/Leydig hamartomas, which are nonencapsulated nodular formations 
constituted by parenchyma similar to the rest of the testicle.
Patients with MAIS frequently consult for infertility. They are phenotypically males with mini-
mal malformations of the external genitalia, simple coronal hypospadias, or a prominent midline 
Figure 8. Focal nodular hyperplasia of Leydig cells in an adult male aged 30 years with cryptorchidism. Testicular 
parenchyma with mixed atrophy shows tubules with spermatogenesis and tubules with only Sertoli cells.
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raphe of the scrotum. On the biopsy, a diffuse hyperplasia of Leydig cells surrounding each of the 
seminiferous tubules is observed. The presence of spermatogenesis varies from case to case [39].
Patients with a defect in 5-α reductase rarely show spermatogenesis, and the seminiferous 
epithelium is reduced to only Sertoli cells with incomplete maturation. The interstitium con-
tains an elevated number of Leydig cells whose morphology is apparently normal.
In adult patients with dysgenetic testis secondary to an abnormal secretion or action of the 
anti-Müllerian hormone (AMH) (Sohval syndrome, male dysgenetic pseudohermaphrodit-
ism, and male with uterus), the function of Leydig cells is poor and many patients have 
hypergonadotropic hypogonadism. Leydig cells are not only increased in number in the 
interstitium but it is worth noting that a high number of Leydig cells are peritubular, forming 
rings in between the tubular wall (Figure 10).
In the testicular tumors secreting β-hCG, a marked diffuse hyperplasia of Leydig cells is generally 
observed. In some cases, and coinciding with burned-out tumors, Leydig cells are not only increased 
Figure 9. Patient of 20 years with 46,XY DSD with complete androgen insensitivity. The diffuse Leydig cells hyperplasia 
contrasts with the prepubertal development of the seminiferous tubules.
Figure 10. Male pseudohermaphroditism patient with dysgenetic testes. Note the presence of concentric rings of Leydig 
cells in the thickness of the tubular wall.
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in number but their cytoplasm is balonized and does not show its characteristic eosinophilia. The 
appearance of a high number of macrophage clusters between the Leydig cells is common.
6.2.1.4. Nodular hyperplasia of Leydig cells
The presence of Leydig cell nodules has classically been considered as one of the more com-
mon histologic features in patients with 47,XXY Klinefelter syndrome. The pathology is asso-
ciated with a diffuse tubular hyalinization with or without the presence of isolated tubules 
with only Sertoli cells or with spermatogenesis (Figure 11).
This form of hyperplasia is more about histological appearance than actual hyperplasia, if 
we consider the small size of the testicles and the disappearance of the seminiferous tubules. 
Both quantitative and qualitative studies have concluded that the number of Leydig cells is not 
increased [40]. The population of Leydig cells present is also not uniform. There are hypertrophic 
cells, involuted cells, and immature cells [41]. In most variants of Klinefelter syndrome, such as 
those with karyotypes 46,XX / 47,XYY, 48,XXYY, 48,XXXY, and 49,XXXY, Leydig cell hyperpla-
sia is less important and can be both nodular and diffuse [42]. The 46,XX males with a normal 
phenotype and normal external genitalia and most patients with microdeletions of the AZF 
region of the Y chromosome also present Leydig cell hyperplasia that is frequently diffuse [43].
6.2.2. Alterations in Leydig cell location
There are two different situations in testicular pathology in which Leydig cells do not have a 
direct relationship with Sertoli cells: when they are located in the perilobular area and when 
they are inside the seminiferous tubules. Perilobular distribution refers to the presence of 
Leydig cells surrounding each testis lobule (Figure 12), characteristic of patients with androgen 
insensitivity, although it is probably a diffuse hyperplasia that isolates the seminiferous tubules.
The other location is inside seminiferous tubules, which have frequently lost the seminiferous 
epithelium (Figure 13). This ectopic location is associated with tubular dysgenesia, such as 
Figure 11. Klinefelter syndrome in a 32-year-old patient who consulted for infertility. Next to a nodular Leydig cells, 
hyperplasia seminiferous tubules with only Sertoli cells and sclerotic tubules are observed.
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Klinefelter syndrome, cryptorchid testicles that do not descend until adult age, and in some 
infertile patients. In many cases, the intratubular Leydig cells are accompanied by blood ves-
sels, probably representing a migration of both Leydig cells and blood vessels normally pres-
ent in the tubular wall to the interior once the cells of the seminiferous epithelium disappear.
6.2.3. Qualitative alterations
Among these alterations are Leydig cells with signs of hypertrophy, xantomized cytoplasm, 
and the presence of lamellar inclusions in the cytoplasm.
6.2.3.1. Cellular hypertrophy
It is common in most cases of hyperplasia; however, various degrees of cell hypertrophy with 
normal Leydig cell groups can coexist in the same testis. Cytoplasmic xantomization is always asso-
ciated with cellular hypertrophy (Figure 14). The appearance of a pale cytoplasm with multiple 
Figure 12. Preferential perilobular distribution of Leydig cells in a patient with complete androgen insensitivity. 
Abundant fibrosis in the interstitium stands out.
Figure 13. Leydig cells inside the sections of two seminiferous tubules in a 42-year-old patient with cryptorchidism. 
In contrast with atrophic characteristics of interstitial Leydig cells, normal-looking or xantomized Leydig cells in 
intratubular location can be observed.
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Figure 14. Testicular biopsy of an azoospermic patient. A cluster of Leydig cells with markedly xantomized cytoplasm 
with persistence of some Reinke crystals is shown. The nuclei of some cells are pyknotic and retracted. The neighboring 
seminiferous tubules lack a germ line.
small vacuoles expresses the unusually high accumulation of lipids. The cells are arranged singly 
or in clusters and are frequently found in patients with cryptorchidism, in DSD with dysgenetic 
testes, in some infertile patients, and in some elderly patients. The fact that these Leydig cells 
very often present with retracted, hyperchromatic nuclei in which it is difficult to recognize the 
nucleolus suggests that these cells have completed their biological cycle and degenerates in this 
way. The relationship with the various pathologies in which they are more frequently found 
makes it possible that many of them are dysgenetic. The presence of lamellar inclusions in the 
cytoplasm of Leydig cells is a characteristic feature of patients with adrenoleukodystrophy. In 
the variety of adrenoleukodystrophy termed adrenomyeloneuropathy, symptoms of gonadal 
dysfunction (loss of libido, erectile dysfunction, scant pubic hair, gynecomastia, and testicular 
atrophy) are observed. The patients also show a decreased seminal volume, oligozoospermia, 
and elevated FSH and LH. In the testis, there is severe and progressive damage of the seminifer-
ous epithelium and alterations in Leydig cells, such as the appearance of lamellar cytoplasmic 
inclusions similar to the ones in adrenal cortex cells and cerebral cells [44].
7. Elderly patients
7.1. Late-onset hypogonadism
Age negatively affects all functions of the male genital tract, especially after age 65, with large 
inter-individual differences. Various terms have been proposed to describe this situation as 
“andropause,” “male climacteric,” “aging male syndrome,” or “symptomatic” androgen defi-
ciency in aging men. “Late-onset hypogonadism” (LOH) has been considered the most appro-
priate term [45, 46]. LOH is a clinical and biochemical syndrome secondary to a decrease in 
the serum levels of free testosterone (total testosterone will still be preserved in serum two or 
three decades longer). This late hypogonadism is already present in 3.1–7.0% of men between 
30 and 69 years of age, but it is found in 18.4% of those over 70 years. The minimum criteria for 
diagnosis have been established when three clinical symptoms are present: decreased libido, 
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morning erection, and erectile dysfunction associated with a total testosterone level of less 
than 11 nml/L and a free testosterone level of less than 220 pmol/L [47, 48]. Hypogonadism in 
some cases has been described as primary and in others as secondary.
7.2. Interpretation of elder testis histology
Assessment of Leydig cells in the elderly is complicated, and it is often difficult to distinguish 
between what might be considered a consequence of normal aging of the Leydig cells and 
what is pathological. Sometimes, the cause is local (varicocele, obstruction of the spermatic 
tract), and other times, it is systemic (the impact of ischemia in a complicated arteriosclerosis, 
hypertension or in chronic diseases and their treatments).
7.2.1. Primary alterations
Primary alterations of Leydig cells consubstantial with physiological aging are as follows: a 
decrease in number, the tendency to form small clusters, cellular atrophy, abundant intra-
nuclear inclusions, multinucleation [49] (Figure 15), an increase in lipofuscins, an increase 
in lipids, immunoexpression of keratins (Figure 16), and a decreased immunohistochemical 
expression of testosterone. The number of Leydig cells at the age of 70 is less than half than 
at 20 years. The tendency to form clusters becomes more important in the peripheral zones of 
the parenchyma, under the albuginea and in the proximities of the testicular mediastinum. 
The cellular atrophy is revealed by pyknotic nuclei, irregular nuclear contours, and reduc-
tions in the size of the cytoplasm [50, 51]. Multinucleation appears around the age of 60 but 
is isolated; it is very frequent toward the age of 70, and from this age, multinucleated cells 
can be observed in more than half of the microscopic fields at high magnification [52]. Not all 
multinucleated cells are Leydig cells; an important percentage of them are telocytes (CD34-
positive fibroblasts). Paracrystalline inclusions become more abundant and are frequently 
observed inside the nucleus [53]. The increase in lipofuscins is progressive and appears in 
both single-nucleated and multinucleated cells [54]. The increase in lipid vacuoles and the 
scarce immunostaining for testosterone is related to involutive changes in the structures 
Figure 15. Multinucleated Leydig cell with typical horseshoe nuclei. Autopsy finding of a 65-year-old patient who died 
of myocardial infarction.
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related to steroidogenesis (e.g., smooth endoplasmic reticulum, mitochondria) [55]. Most of 
the alterations correspond to those of a primary hypogonadism [56, 57].
7.2.2. Secondary alterations
The most well-known secondary changes are secondary to an obstruction, ischemia, mul-
tiple transfusions, acquired hypogonadotropic hypogonadism, and estrogen treatment. 
When the blockage occurs near the testicle, the seminiferous tubules of several lobules 
first dilate and later lose the seminiferous epithelium and become sclerosed. Leydig cells 
acquire a pseudohyperplastic appearance. When a branch of the testicular artery develops 
arteritis or even partial obstruction by arteriosclerosis, the seminiferous tubules atrophy 
and the Leydig cells disappear [58]. This image contrasts with the conservation of the 
surrounding parenchyma. In patients with chronic anemia who undergo multiple transfu-
sions, iron accumulates in the cytoplasm of Leydig cells. In acquired hypogonadotropic 
hypogonadism, an involution of both the seminiferous tubules and the Leydig cells occurs. 
The seminiferous epithelium is reduced to only dedifferentiated Sertoli cells and isolated 
spermatogonia. The thickened tubular wall conserves the elastic fibers, and the Leydig 
cells involute until they disappear. Estrogen treatment was widely used in the past in pros-
tate cancer, although currently it is only used before proceeding to surgical gender change. 
Parallel with the dedifferentiation of the seminiferous epithelium is a rapid involution of 
the Leydig cells, which are reduced to small pyknotic cells with retracted nuclei with some 
cytoplasmic vacuoles [59].
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